| Literature DB >> 30622896 |
Igor Dumic1,2, Danilo Vitorovic3, Scott Spritzer4, Erik Sviggum5, Janki Patel6, Poornima Ramanan7.
Abstract
Acute transverse myelitis (ATM) is a rare, potentially devastating neurological syndrome that has variety of causes, infectious being one of them. Lyme disease (LD) is the most common vector borne zoonosis in the United States (U.S.). While neurologic complications of LD are common, acute transverse myelitis is an exceedingly rare complication. We present a case of a previously healthy 25-year-old man who presented with secondary erythema migrans, aseptic meningitis and clinical features of transverse myelitis including bilateral lower extremity motor and sensory deficits manifesting as weakness and numbness, urinary retention and constipation. Despite negative serum antibodies against Borrelia burgdoferi, cerebrospinal fluid (CSF) was positive for Borrelia burgdorferi PCR. Following treatment with methylprednisolone and ceftriaxone, he attained complete recovery apart from neurogenic bladder necessitating intermittent self-catheterization. We report rare manifestation of a common disease and emphasize the importance of considering LD in the differential diagnosis of acute transverse myelitis, particularly in residents of endemic areas.Entities:
Year: 2018 PMID: 30622896 PMCID: PMC6317275 DOI: 10.1016/j.idcr.2018.e00479
Source DB: PubMed Journal: IDCases ISSN: 2214-2509
Fig. 1This is T2 weighted sagittal image demonstrating intramedullary T2 signal abnormality over a long segment of the thoracic spinal cord (red arrows) without significant cord expansion.
Fig. 2This is an axial T2 weighted image which shows non-expansile T2 signal in the center of the thoracic spinal cord (red arrow).
Summary of negative diagnostic tests that were done in our patient to rule out autoimmune, inflammatory, paraneoplastic and other infectious etiologies of acute transverse myelitis.
| Tests done on serum | Tests done on CSF |
|---|---|
| HSV-1 PCR |
Ag- antigen, Ab- antibody, ANA- Anti-nuclear antibody, AQP-4- Aquaporin-4, CMV- Cytomegalovirus, EBV- Ebstein Barr virus, HBV- Hepatitis B virus, HCV- Hepatitis C virus, HIV- Human immunodeficiency virus, HSV- Herpes simplex virus, NMO- Neuromyelitis optica, PCR -Polymerase chain reaction, RPR - Rapid plasma reagin, RF- Rheumatoid factor, SSA- Anti-Sjogren’s syndrome A, SSB- Anti-Sjogren’s syndrome B, VZV- Varicella zoster virus.
This table summarize all adult cases of neuroborreliosis related transverse myelitis reported in English literature. It includes patients’ demographics, country of origin, most common symptoms and signs as well as treatment and outcome of the diseases.
| Case | Year | Age | Sex | Country | Systemic | Time between symptom onset and diagnosis | Diagnostics | Oligoclonal bands | Erythema migrans | Autonomic dysfunction | Sensory level | Images | Therapy | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1986 | 19 | F | Belgium | none | 2 weeks | CSF WBC-10, 90% lymphocytes; | Positive | Yes | None | T4 | No | Penicillin G for 2 weeks | Improved |
| 2 | 1995 | 42 | M | UK | none | 5 days | LP not done (patient declined) | N/A | Yes | None | C5-6 | MRI | Cefotaxime 6 g/day for 1 week then 8 weeks of doxycycline | Improved |
| 3 | 2002 | 40 | M | France | none | 1 week | CSF WBC-205, 90% lymphocytes. | Yes | Yes | Urinary and bowel incontinence | C2 | MRI | Ceftriaxone 2 g/day for 3 weeks. | Improved |
| 4 | 2005 | 50 | M | France | none | 4 weeks | CSF WBC-16, 100% lymphocytes; Intrathecal | Yes | No | None | Not reported | MRI | Ceftriaxone 4 weeks, doxycycline 4 weeks and IV steroids | Improved |
| 5 | 2008 | 46 | F | Georgia, USA | none | 3 weeks | Positive antibodies in blood (IgM and IgG) | Negative | No | Urinary retention, constipation | T6 | MRI | Ceftriaxone for 1 week plus doxycycline for 3 weeks | Improved |
| 6 | 2009 | 21 | F | Turkey | none | 3 months | CSF WBC-20, 86% lymphocytes. | Negative | No | None | T11 | MRI | Ceftriaxone 4 g/day for 28 days plus (200 mg/day of doxycycline | Improved |
| 7 | 2018 | 25 | M | Wisconsin, USA | none | 2 weeks | CSF WBC 316, 76% lymphocytes, | Negative | Yes | Urinary retention, | T5 | MRI | IV ceftriaxone (28 days) and IV Methylprednisolone (3 days) | Improved |